Drug: LAMIVUDINE. Injury: Hepatitis B DNA increased Quarter: 2016Q3
Total Records: 14 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125823291 | LAMIVUDINE. | Hepatitis B DNA increased | CIPLA | 0.00 | 0 | 20160722 | CN | |
| 126931511 | LAMIVUDINE. | Hepatitis B DNA increased | CIPLA | 0.00 | 0 | 20160829 | KR | |
| 126931621 | LAMIVUDINE. | Hepatitis B DNA increased | CIPLA | 0.00 | 0 | 20160829 | KR | |
| 126931671 | LAMIVUDINE. | Hepatitis B DNA increased | CIPLA | 0.00 | 0 | 20160829 | KR | |
| 127028592 | LAMIVUDINE. | Hepatitis B DNA increased | VIIV | 55.00 YR | M | 58 KG | 20160915 | CN |
| 127029652 | LAMIVUDINE. | Hepatitis B DNA increased | GLAXOSMITHKLINE | 55.00 YR | M | 58 KG | 20160915 | CN |
| 127084491 | LAMIVUDINE. | Hepatitis B DNA increased | GLAXOSMITHKLINE | 60.00 YR | M | 0 | 20160901 | CN |
| 127086671 | LAMIVUDINE. | Hepatitis B DNA increased | VIIV | 60.00 YR | M | 0 | 20160901 | CN |
| 127200661 | LAMIVUDINE. | Hepatitis B DNA increased | VIIV | 56.00 YR | M | 0 | 20160907 | CN |
| 127203091 | LAMIVUDINE. | Hepatitis B DNA increased | GLAXOSMITHKLINE | 56.00 YR | M | 0 | 20160907 | CN |
| 127821891 | LAMIVUDINE. | Hepatitis B DNA increased | CIPLA | 0.00 | 0 | 20160927 | US | |
| 127822641 | LAMIVUDINE. | Hepatitis B DNA increased | CIPLA | 0.00 | 0 | 20160927 | US | |
| 127823661 | LAMIVUDINE. | Hepatitis B DNA increased | CIPLA | 0.00 | 0 | 20160927 | US | |
| 127830711 | LAMIVUDINE. | Hepatitis B DNA increased | CIPLA | 0.00 | 0 | 20160927 | US |
Total Records: 14 Number of Pages: 1